Invention Grant
- Patent Title: Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
-
Application No.: US14773349Application Date: 2014-03-06
-
Publication No.: US10087232B2Publication Date: 2018-10-02
- Inventor: Yaron Ilan , Yoseph Shaaltiel , Uri Hanania , Tali Kizhner , Tami Ariel , Svetlana Gingis-Velitski
- Applicant: Protalix Ltd. , Hadasit Medical Research Services and Development Ltd.
- Applicant Address: IL Carmiel IL Jerusalem
- Assignee: Protalix Ltd.,Hadasit Medical Research Services and Development Ltd.
- Current Assignee: Protalix Ltd.,Hadasit Medical Research Services and Development Ltd.
- Current Assignee Address: IL Carmiel IL Jerusalem
- International Application: PCT/IL2014/050231 WO 20140306
- International Announcement: WO2014/136117 WO 20140912
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/00 ; A61K38/16 ; C07K14/705 ; C07K14/525 ; C12N15/82 ; A61K9/00 ; A61K36/81 ; C07K16/24
Abstract:
A method of treating a TNF Alpha associated medical condition selected from the group consisting of obesity, metabolic syndrome, diabetes and a liver disease or disorder is provided. The method comprising enterally administering to a subject in need thereof a therapeutically effective amount of plant cells expressing a TNF Alpha polypeptide inhibitor, thereby treating the TNF Alpha associated medical condition.
Public/Granted literature
- US20160017019A1 USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY Public/Granted day:2016-01-21
Information query
